Injection of CD4+ and CD8+ cells with donor or host accessory cells induces acute graft-vs-host disease in human skin in immunodeficient mice

Experimental Hematology

Volumn 29, Issue 6, 2001, Pages 720-727

  Matsumoto, Masae ^a   Katoh, Yuko ^a   Nakamura, Yoshihiko ^a   Shimakura, Yasuhito ^a   Hagihara, Masao ^a   Yabe, Hiromasa ^a   Yabe, Miharu ^a   Inokuchi, Sadaki ^a   Kato, Shunichi ^a   Shimamura, Kazuo ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL CULTURE; CELL SELECTION; CELL SUBPOPULATION; CELL SUSPENSION; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; GRAFT VERSUS HOST REACTION; HOST CELL; HUMAN; HUMAN CELL; INJECTION; LYMPHOID CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD14; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPIDERMIS; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HUMANS; KERATINOCYTES; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE TRANSFUSION; MICE; MICE, SCID; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034985906     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00639-7     Document Type: Article

References (32)

1. Graft-vs-host disease
2. Lethal graft-vs-host disease following bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow
3. Transfusion-associated graft-vs-host disease: Risk due to homozygous HLA haplotypes
4. T-cell depletion for GVHD prevention in humans
5. Cytokine cascade in acute graft-vs-host disease
6. The role of cytokines in acute graft-vs-host disease
7. Properties of purified T-cell subsets. II. In vivo response to class I vs. class II differences
8. Role of T-cell subsets in lethal graft-vs-host disease (GVHD) directed to class I vs class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II H-2 differences
9. Role of T-cell subsets in lethal graft-vs-host disease (GVHD) directed to class I vs class II differences. I. L3T4+cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I-different hosts
10. + effector cells
11. Acute cutaneous graft-vs-host disease to minor histocompatibility antigens in a murine model
12. Identity of immune cells in graft-vs-host disease of the skin. A study using monoclonal antibodies by indirect immunofluorescence
13. T-lymphocyte subsets in the lesional skin of allogeneic and autologous bone marrow transplant patients
14. Immunohistochemical study of skin lesions in acute and chronic graft-vs-host disease following bone marrow transplantation
15. Immunological analysis of the skin in graft-vs-host disease
16. Identification of natural killer (NK) cells in lesions of human cutaneous graft-vs-host disease: Expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates
17. Suppression of graft-vs-host disease and amplification of graft-vs-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation
18. An in vivo model of human skin acute graft-vs-host disease: Transplantation of cultured human epidermal cells and dermal fibroblasts with human lymphocytes into SCID mice
19. Effects of fibroblasts of different origin on long-term maintenance of xenotransplanted human epidermal keratinocytes in immunodeficient mice
20. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: Existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways
21. Mixed epidermal cell-lymphocyte reaction in prediction of acute graft-vs-host disease in bone marrow recipients
22. + T lymphocytes for prevention of graft-vs-host disease after allogeneic bone marrow transplantation
23. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients
24. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation
25. + keratinocytes
26. Mechanisms of T-cell recognition of alloantigen. The role of peptides
27. The role of T-cell costimulatory activation pathways in transplant rejection
28. Contribution of direct and indirect recognition pathways to T-cell alloreactivity
29. Induction of intestinal graft-vs-host reaction across mutant major histocompatibility antigens by T-lymphocyte subsets in mice
30. The role of cytokines in graft-vs-host reactions and disease
31. Prevention of graft vs host disease by inactivation of host antigen-presenting cells
32. Reciprocal control of T-helper cell and dendritic cell differentiation